Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?

OBJECTIVES: To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to evaluate whether the addition of dynamic contrast–enhanced imaging (DCE) improves the overall visibility. METHODS: We retrospectively evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huebner, Nicolai Alexander, Korn, Stephan, Resch, Irene, Grubmüller, Bernhard, Gross, Tobias, Gale, Robert, Kramer, Gero, Poetsch, Nina, Clauser, Paola, Haitel, Andrea, Fajkovic, Harun, Shariat, Shahrokh F., Baltzer, Pascal A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Urogenital
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128749/
https://www.ncbi.nlm.nih.gov/pubmed/33263793
http://dx.doi.org/10.1007/s00330-020-07494-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128749/
https://www.ncbi.nlm.nih.gov/pubmed/33263793
http://dx.doi.org/10.1007/s00330-020-07494-1

Ejemplares similares